Market Summary
Markets traded nervously as major indices tread water: S&P 500 flat, Nasdaq mixed and Dow under pressure amid elevated volatility. AI and chip names led sector moves while bank and travel stocks lagged; catalysts include the Supreme Court tariff case, BoE’s tight vote and the government shutdown’s looming flight cuts.
The US government shutdown has become the longest on record and is forcing federal agencies to curb operations. Regulators are preparing sweeping flight cuts that will disrupt travel and commerce if lawmakers don’t reach a deal.
Figure of the Day
15 billion USD – Estimated weekly economic cost of the U.S. government shutdown.
The Supreme Court signalled deep scepticism about President Trump’s use of emergency powers to impose global tariffs. The hearings could decide whether the administration’s signature trade tool survives legal scrutiny.
The Bank of England held rates in a razor‑thin vote, flagging a possible cut soon as inflation shows signs of easing. Markets are weighing whether the decision presages looser policy ahead of the Autumn Budget.
Bullish
Arm beats and raises guidance — chip design strength powers rally
Arm reported another strong quarter and lifted guidance, underscoring rising demand for AI compute and sending the stock higher as investors reward scalable IP business models.
More on barrons.com
Layoff announcements surged in October, hitting levels not seen in decades as companies restructure around AI and cost cuts. Challenger and other data show rising job cuts, raising recession concerns for markets and policymakers.
Nvidia’s CEO stoked controversy by warning China will win the AI race, then softened his comments. The episode pressured markets and reignited debate over US competitiveness in semiconductors and AI.
Bearish
UPS freighter explodes after takeoff — deadly crash disrupts logistics
A UPS cargo jet crashed and exploded after takeoff from Louisville, killing multiple crew and sparking an NTSB probe that will shave near‑term capacity from global shipping routes.
More on youtube.com
Beijing is ordering state‑funded projects to use domestic AI chips and blocking foreign silicon from some data centres. The measures tighten China’s tech self‑reliance push and threaten big US chipmakers’ access to state projects.
Snap struck a blockbuster $400m deal with Perplexity to add AI search to Snapchat, spurring a big stock move. The pact underscores how consumer apps are buying AI functionality at scale to revive growth.
Regulatory Impact
China ordered state‑funded data centres to use local AI chips; France moved to suspend Shein’s online market; FAA to cut flight capacity during the US shutdown — each signals tighter tech, consumer and aviation rules.
Alphabet is in talks to deepen AI investments globally while exploring stakes in rivals — moves that reshape the competitive map. Plans for remote data centres and Anthropic investment signal a multibillion‑dollar escalation in cloud‑AI infrastructure.
Valuation gauges flash warning signs as CAPE and other measures climb toward dot‑com levels. Investors are debating whether lofty AI‑led rallies signal euphoria or durable re‑rating of tech profits.
Quote
“China is going to win the AI race.”
— Jensen Huang, Nvidia CEO
Regulators are ramping up enforcement in crypto as traditional and new players battle over rules and market structure. Big fines and fresh capital for firms show the sector remains under close scrutiny even as investment pours back in.
Space and spectrum assets continue to consolidate as satellite and broadband firms jockey for capacity. EchoStar and SpaceX deals mark another wave of stock‑for‑spectrum transactions reshaping the orbital telecom market.
A UPS cargo plane crash in Louisville has sparked a major safety probe and will ripple through logistics and supply chains. Regulators and carriers are assessing impacts on capacity and peak‑season deliveries.
SoftBank reportedly explored a takeover of Marvell as part of consolidation moves in chips and IP. The approach underscores continued M&A pressure across semiconductor design and infrastructure.
Big pharma is doubling down on obesity and premium therapies as takeover battles and late‑stage trials accelerate industry consolidation. Bids for Metsera and Lilly’s new trial starts signal fast‑moving M&A and R&D dynamics.
Moderna cut its top‑line guidance after weaker Covid‑vaccine sales, reflecting a tougher demand mix and industry headwinds. Results and revised profit forecasts have knocked sentiment across biotech peers.
Shein’s retail push in Paris has been met by protests and a swift government response over illegal listings. French authorities moved to suspend the site even as the company defends its bricks‑and‑mortar expansion.
Ukraine and Russia continue tit‑for‑tat strikes, hitting military and energy targets. Both sides report successful operations, keeping the region on edge and energy markets alert to escalation risks.
Regulatory pain and probes are hitting Europe’s financial infrastructure and banks. A record fine for JPMorgan and an EU investigation into exchanges underline rising scrutiny of market players.
